SigutLabs

SigutLabs is a specialized chemistry-focused CRO based in Prague, Czech Republic, providing high-end custom synthesis, novel route development, and process scale-up services. The company has established a strong reputation for rapid delivery and scientific expertise, particularly in complex chemistry for advanced therapeutics like antibody-drug conjugates (ADCs) and antiviral compounds. Its business model is purely service-based, generating revenue through client projects, and it has demonstrated growth through partnerships with global research institutions and listings on major CRO platforms. While not developing its own therapeutics, SigutLabs positions itself as a critical enabler for drug discovery and development programs worldwide.

Advanced synthetic organic chemistry expertise in linker-payloads (ADCs), nucleoside/nucleotide chemistry, peptide chemistry, click-chemistry, and organometallic chemistry, supported by scale-up and analytical capabilities.

SigutLabs competes in the fragmented chemistry CRO market against large players like Lonza, Charles River, and Eurofins, as well as numerous small, niche laboratories. Its differentiation lies in its deep, PhD-level focus on complex synthetic challenges (especially ADC chemistry), rapid turnaround times, and a cost-effective EU location. It must continually prove its value against both the breadth of large CROs and the agility of other small specialists.